Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Top Stories > Ping An Good Doctor Obtains Pharmaceutical Trade Licence (Wholesale)

Ping An Good Doctor Obtains Pharmaceutical Trade Licence (Wholesale)

Published by Gbaf News

Posted on July 24, 2018

3 min read

Last updated: January 21, 2026

Graph illustrating decline in German retail sales amid COVID-19 restrictions - Global Banking & Finance Review — This image depicts a graph showing the significant drop in German retail sales as COVID-19 restrictions impacted consumer behavior during the holiday season. The decline of 5.5% in December highlights the economic challenges faced by Germany's retail sector amid ongoing pandemic regulations.

China’s leading one-stop healthcare ecosystem platform, Ping An Healthcare and Technology Company Limited (“Ping An Good Doctor”, the “Company”, stock code: 1833.HK), is pleased to announce that the Company recently obtained the Pharmaceutical Trade Licence (Wholesale) (“the Licence”).

With the Licence, Ping An Good Doctor is able to develop its online and offline pharmaceutical business-to-business (B2B) business and pharmaceutical wholesale business, which will facilitate the sales of the Company’s health mall business and the consolidation of its resources.

The health mall business of Ping An Good Doctor commenced on August 2015, and it is operated under a direct sales model and marketplace model. The health mall provides users with diversified and evolving product offerings, including medicines, Chinese medicines, fitness equipment and personal care products. As of 31 December 2017, the health mall offered approximately 178,800 stock keeping units (SKU) with rapid growth in gross merchandise volume (GMV). Its GMV in 2017 reached RMB1.193 billion, representing a year-on-year growth of 536.8%.

During its annual “Double Seven Health Festival” from 7-12 July 2018, the health mall business of Ping An Good Doctor achieved a revenue growth of 188% year-on-year. More than 500 merchants and 5,000 pharmaceutical brands participated in the event, and the number of customers who made purchases increased by 60% compared with the previous year.

China’s leading one-stop healthcare ecosystem platform, Ping An Healthcare and Technology Company Limited (“Ping An Good Doctor”, the “Company”, stock code: 1833.HK), is pleased to announce that the Company recently obtained the Pharmaceutical Trade Licence (Wholesale) (“the Licence”).

With the Licence, Ping An Good Doctor is able to develop its online and offline pharmaceutical business-to-business (B2B) business and pharmaceutical wholesale business, which will facilitate the sales of the Company’s health mall business and the consolidation of its resources.

The health mall business of Ping An Good Doctor commenced on August 2015, and it is operated under a direct sales model and marketplace model. The health mall provides users with diversified and evolving product offerings, including medicines, Chinese medicines, fitness equipment and personal care products. As of 31 December 2017, the health mall offered approximately 178,800 stock keeping units (SKU) with rapid growth in gross merchandise volume (GMV). Its GMV in 2017 reached RMB1.193 billion, representing a year-on-year growth of 536.8%.

During its annual “Double Seven Health Festival” from 7-12 July 2018, the health mall business of Ping An Good Doctor achieved a revenue growth of 188% year-on-year. More than 500 merchants and 5,000 pharmaceutical brands participated in the event, and the number of customers who made purchases increased by 60% compared with the previous year.